Advertisement
Australia markets closed

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     

  • AUD/USD

    0.6513
    +0.0012 (+0.19%)
     

  • OIL

    82.97
    +0.16 (+0.19%)
     

  • GOLD

    2,330.10
    -8.30 (-0.35%)
     

  • Bitcoin AUD

    98,761.14
    -3,755.98 (-3.66%)
     

  • CMC Crypto 200

    1,386.86
    -37.24 (-2.62%)
     

  • AUD/EUR

    0.6077
    +0.0007 (+0.11%)
     

  • AUD/NZD

    1.0954
    +0.0012 (+0.11%)
     

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     

  • DAX

    18,088.70
    -48.95 (-0.27%)
     

  • Hang Seng

    17,275.84
    +74.57 (+0.43%)
     

  • NIKKEI 225

    37,628.57
    -831.51 (-2.16%)
     

Berkeley Lights to Participate in the Cowen 41st Annual Healthcare Conference

Berkeley Lights, Inc
·1-min read

EMERYVILLE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcoming Cowen 41st Annual Healthcare Conference.

Berkeley Lights’ management is scheduled to participate in a fireside chat on Thursday, March 4 at 11:10 a.m. Pacific Time / 2:10 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.berkeleylights.com.

About Berkeley Lights
Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect™ chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain.

Berkeley Lights’ Beacon® and Lightning™ systems and Culture Station™ instrument are FOR RESEARCH USE ONLY. Not for use in diagnostic procedures.

Press Contact
berkeleylights@bulleitgroup.com

Investor Contact
ir@berkeleylights.com